Pan Long
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
-
- Cancer-related molecular mechanisms research
Papers in
-
- Retinal Development and Disorders 5
- Heme Oxygenase-1 and Carbon Monoxide 4
- Medicinal Plants and Bioactive Compounds 3
-
- Retinal Diseases and Treatments 11
- Co-authors
- Weiming Yan (12 shared papers)Tao Chen (9 shared papers)Xudong Wen (10 shared papers)Zuoming Zhang (9 shared papers)Shiqiang Xiong (5 shared papers)Siwang Wang (3 shared papers)Chengming Li (3 shared papers)Jun Hou (3 shared papers)
In The Last Decade
Pan Long
34 papers receiving 384 citations
Peers
Comparison fields: 5 of 95
- Ophthalmology 71
- Cancer Research 68
- Neurology 37
- Clinical Biochemistry 28
- Complementary and alternative medicine 26
Countries citing papers authored by Pan Long
This map shows the geographic impact of Pan Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Long more than expected).
Fields of papers citing papers by Pan Long
This network shows the impact of papers produced by Pan Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Long. The network helps show where Pan Long may publish in the future.
Co-authors
The 25 scholars most cited alongside Pan Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 56 | |
| 2 | 2018 | 34 | |
| 3 | 2018 | 22 | |
| 4 | 2019 | 20 | |
| 5 | 2020 | 20 | |
| 6 | 2019 | 20 | |
| 7 | 2021 | 18 | |
| 8 | 2023 | 18 | |
| 9 | 2019 | 16 | |
| 10 | 2018 | 14 | |
| 11 | 2022 | 13 | |
| 12 | 2023 | 13 | |
| 13 | 2023 | 13 | |
| 14 | 2019 | 12 | |
| 15 | 2020 | 12 | |
| 16 | 2020 | 11 | |
| 17 | 2022 | 10 | |
| 18 | 2018 | 10 | |
| 19 | 2017 | 8 | |
| 20 | Silencing of CXCR4 and CXCR7 expression by RNA interference suppresses human endometrial carcinoma growth in vivo. | 2017 | 8 |
About Pan Long
Pan Long is a scholar working on Molecular Biology, Ophthalmology, Surgery, Clinical Biochemistry and Complementary and alternative medicine, having authored 36 papers that have together received 389 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Retinal Development and Disorders (5 papers), Advanced Glycation End Products research (5 papers), Hydrogen's biological and therapeutic effects (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Anesthesia and Neurotoxicity Research (3 papers), Medicinal Plants and Bioactive Compounds (3 papers) and High Altitude and Hypoxia (3 papers). The work is most often cited by research in Ophthalmology (71 citations), Cancer Research (68 citations), Neurology (37 citations), Clinical Biochemistry (28 citations) and Complementary and alternative medicine (26 citations). Pan Long has collaborated with scholars based in China, Canada and Japan. Frequent co-authors include Weiming Yan, Tao Chen, Xudong Wen, Zuoming Zhang, Shiqiang Xiong, Siwang Wang, Chengming Li, Jun Hou, Zhen Zhang and Yonghe Hu. Their work appears in journals such as Journal of Inflammation Research, International Immunopharmacology, BMC Ophthalmology, Frontiers in Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.